Predicts in vivo pharmacokinetics from structure alone: plasma clearance, steady-state volume, and residence time in four preclinical species.
VHH developability model predicting five biophysical endpoints from nanobody sequence, using the ESMC protein language model with conformal bounds.
Small-molecule ADME/Tox prediction from a SMILES string, covering 33 correlated ADMET endpoints in one multi-task model with conformal uncertainty.
Multi-task antibody developability model predicting 18 biophysical endpoints from heavy- and light-chain sequence, trained on Lilly assay data.